Laparoscopic Anatomic vs. Nonanatomic Liver Resection for Large Hepatocellular Carcinoma (≥5 cm) in the Right Lobe

医学 肝细胞癌 切除缘 倾向得分匹配 外科 入射(几何) 切除术 肝切除术 波瓣 腹腔镜检查 内科学 病理 物理 光学
作者
ahmed badawy,Ho‐Seong Han,Tamer M. Elmahdy,Hossam Eldeen M. Soliman,Mohammad Hamdy Abo‐Ryia,Osama Helmy El-Khadrawy
出处
期刊:Hpb [Elsevier BV]
标识
DOI:10.1016/j.hpb.2024.01.005
摘要

Objective To determine the impacts and outcomes of laparoscopic anatomic liver resection (LAR) and laparoscopic nonanatomic resection (LNAR) in patients with large hepatocellular carcinoma (HCC) in the right lobe of the liver. Background There are few comparative studies of LAR and LNAR for large HCC. Method Three hundred thirty-seven patients underwent liver resection for large HCC (≥5 cm) at Seoul National University Bundang Hospital, Seoul, Korea, between January 2004 and December 2022. After the exclusion of patients treated with open hepatic resection and those who had left-lobe or bilobar tumors, 94 patients were ultimately included. Patients were divided into LAR group (61 patients) and LNAR group (33 patients). After propensity score matching (PSM) with 1:1 matching, 31 patients were included in each group. The outcomes in the two groups were compared. Results LAR group had longer operative time than LNAR group (333.7 ± 113.7 vs 210 ± 117.6 min, respectively, P < 0.001), wider safety margin (1.4 ± 1.5 vs 0.7 ± 0.7 cm, respectively, P = 0.015), and lower incidence of recurrence (25.8% vs. 54.8%, respectively, P = 0.021). Conclusion LAR required longer operative time, achieved wider safety margin, and had lower incidence of recurrence than LNAR. To determine the impacts and outcomes of laparoscopic anatomic liver resection (LAR) and laparoscopic nonanatomic resection (LNAR) in patients with large hepatocellular carcinoma (HCC) in the right lobe of the liver. There are few comparative studies of LAR and LNAR for large HCC. Three hundred thirty-seven patients underwent liver resection for large HCC (≥5 cm) at Seoul National University Bundang Hospital, Seoul, Korea, between January 2004 and December 2022. After the exclusion of patients treated with open hepatic resection and those who had left-lobe or bilobar tumors, 94 patients were ultimately included. Patients were divided into LAR group (61 patients) and LNAR group (33 patients). After propensity score matching (PSM) with 1:1 matching, 31 patients were included in each group. The outcomes in the two groups were compared. LAR group had longer operative time than LNAR group (333.7 ± 113.7 vs 210 ± 117.6 min, respectively, P < 0.001), wider safety margin (1.4 ± 1.5 vs 0.7 ± 0.7 cm, respectively, P = 0.015), and lower incidence of recurrence (25.8% vs. 54.8%, respectively, P = 0.021). LAR required longer operative time, achieved wider safety margin, and had lower incidence of recurrence than LNAR.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
三七发布了新的文献求助25
刚刚
六尺巷完成签到,获得积分10
1秒前
Kxxxx发布了新的文献求助10
2秒前
2秒前
3秒前
潇湘夜雨发布了新的文献求助10
3秒前
岁月如歌完成签到,获得积分10
4秒前
橘子皮完成签到,获得积分10
5秒前
ciciyu完成签到,获得积分10
6秒前
微笑的水桃完成签到 ,获得积分10
7秒前
7秒前
科研通AI6.1应助YY采纳,获得10
8秒前
8秒前
大胖厨爱吃小炒肉完成签到,获得积分10
8秒前
YWY完成签到,获得积分0
9秒前
阳光的凡阳完成签到 ,获得积分10
10秒前
袁睿韬完成签到 ,获得积分10
12秒前
李健的小迷弟应助禾之采纳,获得10
12秒前
ciciyu发布了新的文献求助10
12秒前
123发布了新的文献求助10
12秒前
研友_Lw7MKL发布了新的文献求助10
13秒前
13秒前
16秒前
威武雅容完成签到 ,获得积分10
17秒前
dreamode完成签到,获得积分0
18秒前
CC完成签到 ,获得积分10
19秒前
leshu发布了新的文献求助10
20秒前
大胆路人完成签到 ,获得积分10
20秒前
李木子完成签到 ,获得积分10
24秒前
难过忆山完成签到,获得积分10
24秒前
24秒前
xjllp6发布了新的文献求助10
25秒前
乐观柚子完成签到,获得积分10
26秒前
单纯的乐曲完成签到,获得积分10
26秒前
糖糖糖86完成签到,获得积分10
28秒前
Semy应助难过忆山采纳,获得10
28秒前
上官若男应助ciciyu采纳,获得10
28秒前
花样年华完成签到,获得积分10
28秒前
徐笑松发布了新的文献求助10
30秒前
喝下午茶的狗完成签到,获得积分10
30秒前
高分求助中
论现代体育科学研究的方法学特征 1000
Invited Discussant 63O and 64O 1000
Ideology and Meaning-Making under the Putin Regime 750
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
Petrology and Plate Tectonics 500
A Handbook of User Experience Research & Design in Libraries 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6914660
求助须知:如何正确求助?哪些是违规求助? 8606393
关于积分的说明 18261156
捐赠科研通 6326215
什么是DOI,文献DOI怎么找? 3067887
关于科研通互助平台的介绍 2095334
邀请新用户注册赠送积分活动 2045203